These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26466651)

  • 1. Regimens for the Hepatitis C Treatment-Naive Patient.
    Ayoub WS; Tran TT
    Clin Liver Dis; 2015 Nov; 19(4):619-27, v. PubMed ID: 26466651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regimens for Cirrhotic Patients.
    Kwo PY
    Clin Liver Dis; 2015 Nov; 19(4):657-67, vi. PubMed ID: 26466654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-Acting Antiviral Agents: Regimens for the Interferon Failure Patient.
    Kushner T; Khungar V
    Clin Liver Dis; 2015 Nov; 19(4):629-39, v-vi. PubMed ID: 26466652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues.
    Feld JJ
    Curr Drug Targets; 2017; 18(7):851-862. PubMed ID: 26302808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals.
    Dietz J; Susser S; Vermehren J; Peiffer KH; Grammatikos G; Berger A; Ferenci P; Buti M; Müllhaupt B; Hunyady B; Hinrichsen H; Mauss S; Petersen J; Buggisch P; Felten G; Hüppe D; Knecht G; Lutz T; Schott E; Berg C; Spengler U; von Hahn T; Berg T; Zeuzem S; Sarrazin C;
    Gastroenterology; 2018 Mar; 154(4):976-988.e4. PubMed ID: 29146520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis.
    Bailly F; Pradat P; Virlogeux V; Zoulim F
    Dig Dis; 2015; 33(4):613-23. PubMed ID: 26159282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Virologic Failure with Direct-Acting Antivirals in Hepatitis C and Strategies for Retreatment.
    Costilla V; Mathur N; Gutierrez JA
    Clin Liver Dis; 2015 Nov; 19(4):641-56, vi. PubMed ID: 26466653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegylated interferon based therapy with second-wave direct-acting antivirals in genotype 1 chronic hepatitis C.
    Welch NM; Jensen DM
    Liver Int; 2015 Jan; 35 Suppl 1():11-7. PubMed ID: 25529082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus protease inhibitor-resistance mutations: our experience and review.
    Wu S; Kanda T; Nakamoto S; Imazeki F; Yokosuka O
    World J Gastroenterol; 2013 Dec; 19(47):8940-8. PubMed ID: 24379619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paediatric hepatitis C virus infection and its treatment: Present, past, and future.
    El-Shabrawi M; Hassanin F
    Arab J Gastroenterol; 2019 Sep; 20(3):163-174. PubMed ID: 31585703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of drug resistance mutations of NS3 inhibitors in chronic hepatitis C patients infected with genotype 1].
    Şanlıdağ T; Sayan M; Akçalı S; Kasap E; Buran T; Arıkan A
    Mikrobiyol Bul; 2017 Apr; 51(2):145-155. PubMed ID: 28566078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of hepatitis C virus baseline polymorphism during the antiviral therapy].
    Tornai I
    Orv Hetil; 2015 May; 156(21):849-54. PubMed ID: 26038992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.
    Kowdley KV; Lawitz E; Poordad F; Cohen DE; Nelson DR; Zeuzem S; Everson GT; Kwo P; Foster GR; Sulkowski MS; Xie W; Pilot-Matias T; Liossis G; Larsen L; Khatri A; Podsadecki T; Bernstein B
    N Engl J Med; 2014 Jan; 370(3):222-32. PubMed ID: 24428468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-Generation Regimens: The Future of Hepatitis C Virus Therapy.
    Vizuete J; Hubbard H; Lawitz E
    Clin Liver Dis; 2015 Nov; 19(4):707-16, vii. PubMed ID: 26466657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New era in the treatment of chronic hepatitis C - novel direct acting antivirals].
    Horváth G; Halász T; Makara M; Hunyady B
    Orv Hetil; 2015 May; 156(21):841-8. PubMed ID: 26038991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-Label Study of Patients With Genotype 1b Chronic Hepatitis C Virus Infection With and Without Cirrhosis.
    Lawitz E; Makara M; Akarca US; Thuluvath PJ; Preotescu LL; Varunok P; Morillas RM; Hall C; Mobashery N; Redman R; Pilot-Matias T; Vilchez RA; Hézode C
    Gastroenterology; 2015 Oct; 149(4):971-80.e1. PubMed ID: 26170136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meet the Classes of Directly Acting Antiviral Agents: Strengths and Weaknesses.
    Chacko KR; Gaglio PJ
    Clin Liver Dis; 2015 Nov; 19(4):605-17, v. PubMed ID: 26466650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.
    Sulkowski MS; Gardiner DF; Rodriguez-Torres M; Reddy KR; Hassanein T; Jacobson I; Lawitz E; Lok AS; Hinestrosa F; Thuluvath PJ; Schwartz H; Nelson DR; Everson GT; Eley T; Wind-Rotolo M; Huang SP; Gao M; Hernandez D; McPhee F; Sherman D; Hindes R; Symonds W; Pasquinelli C; Grasela DM;
    N Engl J Med; 2014 Jan; 370(3):211-21. PubMed ID: 24428467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders.
    Chayama K; Takahashi S; Toyota J; Karino Y; Ikeda K; Ishikawa H; Watanabe H; McPhee F; Hughes E; Kumada H
    Hepatology; 2012 Mar; 55(3):742-8. PubMed ID: 21987462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory study of oral combination antiviral therapy for hepatitis C.
    Poordad F; Lawitz E; Kowdley KV; Cohen DE; Podsadecki T; Siggelkow S; Heckaman M; Larsen L; Menon R; Koev G; Tripathi R; Pilot-Matias T; Bernstein B
    N Engl J Med; 2013 Jan; 368(1):45-53. PubMed ID: 23281975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.